Send to

Choose Destination
Expert Rev Anti Infect Ther. 2006 Dec;4(6):953-6.

First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapy.

Author information

University of Alberta, Department of Biochemistry, 315C Heritage Medical Research Center, Edmonton, Alberta, Canada.


Viral replication and pathogenesis involves many cellular protein kinases, and many specific inhibitors of such kinase have been developed for the treatment of noninfectious diseases. As expected, such drugs have been repeatedly demonstrated to inhibit viral replication in cultured cells. Cellular protein kinases have thus been considered for several years as potentially valid targets for antiviral therapy. However, until recently there was no proof of such activity in vivo. The three papers discussed herein demonstrate that inhibitors of cellular protein kinases are indeed effective for the treatment of virus-induced disease in animal models and human clinical trials.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center